Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Alnylam Pharmaceuticals, Inc.
(NQ:
ALNY
)
29.99
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
29.73
Bid (Size)
0.0100 (100)
Ask (Size)
33.00 (200)
Prev. Close
29.99
Today's Range
29.59 - 30.19
52wk Range
11.20 - 31.79
Shares Outstanding
62,171,037
Dividend Yield
N/A
Top News
More News
Commit To Buy Alnylam Pharmaceuticals At $25, Earn 22.8% Annualized
June 17, 2013
Investors eyeing a purchase of Alnylam Pharmaceuticals Inc (ALNY) stock, but tentative about paying the going market price of $30.07/share, might benefit from considering selling puts among the...
Read More
category
Dividends
from
Dividend Channel
Commit To Buy Alnylam Pharmaceuticals At $25, Earn 22.8% Annualized
June 17, 2013
Investors eyeing a purchase of Alnylam Pharmaceuticals Inc (ALNY) stock, but tentative about paying the going market price of $30.07/share, might benefit from considering selling puts among the...
Read More
category
Stocks
from
Market News Video
More News
Read More
Recent 52-Week High Exceeded in Shares of Alnylam Pharmaceuticals (ALNY)
June 11, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Morgan Stanley Initiates Alnylam Pharmaceuticals at Overweight on Market Leader Position
June 11, 2013
category
Benzinga
,
ALNY
,
Morgan Stanley
, and 4 more.
from
Latest Articles from Benzinga.com
UPDATE: Morgan Stanley Initiates Alnylam Pharmaceuticals at Overweight on Positively Viewed Amyloidosis Program
June 11, 2013
category
Benzinga
,
ALNY
,
Morgan Stanley
, and 4 more.
from
Latest Articles from Benzinga.com
Morgan Stanley Starts Alnylam Pharmaceuticals (ALNY) at Overweight
June 11, 2013
from
StreetInsider.com News Articles
Lightning Round: Visa, Micron & More
June 06, 2013
category
Citigroup Inc/
,
Titan International
,
Citigroup Inc
, and 13 more.
from
CNBC.com News
Alnylam to Webcast Presentation at Goldman Sachs 34th Annual Global Healthcare Conference
June 06, 2013
from
Business Wire News Releases
Alnylam Pharmaceuticals: The Winning Streak Continues (ALNY)
May 31, 2013
from
Comtex SmarTrend® News Briefs
Alnylam Pharmaceuticals: The Winning Streak Continues (ALNY)
May 28, 2013
from
Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.